T-group (topology)
210.1.6 Gamma-glutamyltranspeptidase-like
Ligands and drugs
271
Member domains
107
with ligand contacts (≤ 4 Å)
39.5% of members
81
with DrugDomain annotations
29.9% of members
50
with a DrugBank compound
18.5% of members
Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.
Chemical profile
Chemical profiles are computed for X-groups. 210.1.6 belongs to X-group 210 Ntn/PP2C, which binds 7.8 ligand superclasses per 20 proteins, broader than 53% of the 256 X-groups with enough proteins to compare. View its chemical profile →
DrugBank compounds
| DrugBank | PDB ligand | Name | Domains |
|---|---|---|---|
| DB00141 | NAG | N-Acetylglucosamine | 24 |
| DB00142 | GLU | Glutamic acid | 14 |
| DB00145 | GLY | Glycine | 9 |
| DB03686 | GTB | S-(4-nitrobenzyl)glutathione | 4 |
| DB04699 | GBL | gamma-Butyrolactone | 4 |
| DB00143 | GSH | Glutathione | 2 |
Most frequently bound compounds
| PDB ligand | Name | Domains in contact |
|---|---|---|
| GLU | GLUTAMIC ACID | 26 |
| CL | CHLORIDE ION | 24 |
| NAG | 2-acetamido-2-deoxy-beta-D-glucopyranose | 24 |
| NAmetal | SODIUM ION | 19 |
| CAmetal | CALCIUM ION | 13 |
| AVN | (2S)-AMINO[(5S)-3-CHLORO-4,5-DIHYDROISOXAZOL-5-YL]ACETIC ACID | 12 |
| AZS | O-DIAZOACETYL-L-SERINE | 10 |
| GLY | GLYCINE | 10 |
| DON | 6-DIAZENYL-5-OXO-L-NORLEUCINE | 7 |
| 4UD | (2S)-amino[(5S)-4,5-dihydro-1,2-oxazol-5-yl]acetic acid | 4 |
| 6FY | (2~{S})-2-azanyl-4-[(2~{R})-1-(2-hydroxy-2-oxoethylamino)-1-oxidanylidene-butan-2-yl]oxyphosphonoyl-butanoic acid | 4 |
| GGL | GAMMA-L-GLUTAMIC ACID | 4 |
| GTB | S-(P-NITROBENZYL)GLUTATHIONE | 4 |
| GBL | GAMMA-BUTYROLACTONE | 3 |
| MGmetal | MAGNESIUM ION | 3 |
| 4M8 | (2S)-2-amino-4-[(S)-hydroxy(methoxy)phosphoryl]butanoic acid | 2 |
| 8WY | 5,5-dihydroxy-L-norleucine | 2 |
| GSH | Glutathione | 2 |
| IOD | IODIDE ION | 2 |
| SEE | trihydroxy(L-serinato-kappaO~3~)borate(1-) | 2 |